AI-based triage for stroke imaging is associated with reductions in multiple workflow intervals, but the supporting evidence is predominantly observational and concentrated around a small number of commercial platforms. A 2026 systematic review and meta-analysis in CardioVascular and Interventional Radiology reports reductions of 17.12 minutes in door-to-groin puncture, 26.55 minutes in door-to-first pass, 14.55 minutes in door-to-revascularization, 4.44 minutes in door-to-needle, and 36.8 minutes in door-in-door-out time [1]. The same review concludes that randomized controlled trials are still needed to confirm effectiveness [1]. For imaging leaders and stroke program directors, the practical question is not whether AI can flag suspected large vessel occlusion or hemorrhage, but how to evaluate a specific workflow against local referral patterns, reader availability, and integration constraints.
The Named Workflow: Triage, Notification, and Escalation
The workflow under study begins when a noncontrast CT or CT angiography study is acquired for a patient with suspected acute stroke. An AI module analyzes the images and generates a suspected large vessel occlusion or intracranial hemorrhage notification, which is routed to a stroke clinician or radiologist through a mobile or desktop application [6][7]. The AHA scientific statement describes this as allowing nonradiology professionals access to complex neuroimaging results in real time, remotely, across multiple facilities [7]. The notification is intended to trigger earlier activation of the thrombectomy or thrombolysis pathway before a formal radiology interpretation is completed.
The Mayo Clinic telestroke evaluation provides a concrete example of this escalation logic. The authors hypothesized that AI support would increase treatment rates and reduce treatment times through earlier recognition of large vessel occlusion, improved telestroke physician confidence, and capture of patients with early ischemic changes that might otherwise receive an alternative diagnosis [5]. In that prospective pre-post study, the rate of intravenous thrombolysis treatment delivery rose from 26.6% to 35.0% of potentially eligible patients after implementation, a change that was not statistically significant (P=.24) [5]. The study authors note that most telestroke consultations are completed prior to formal radiology interpretation, which makes the AI notification a parallel rather than replacement signal [5].
Technical Decision Points: Inputs, Thresholds, and Reader Roles
A central technical decision is which imaging input the AI module receives. A multicenter retrospective study evaluated a deep learning tool for detecting intracranial hemorrhage and anterior circulation large vessel occlusion on noncontrast CT alone [6]. The hemorrhage module achieved a sensitivity of 94.9% (95% CI, 88.4%–98.3%) and specificity of 99.0% (95% CI, 94.7%–99.9%) with an area under the receiver operating characteristic curve of 0.974, while the large vessel occlusion module achieved a sensitivity of 81.6% and specificity of 87.1% with an area under the curve of 0.915 [6]. These figures describe performance against ground truth established by neuroradiologists, not against the general radiologist interpretation that often precedes specialist review in community settings.
The choice of noncontrast CT versus CT angiography as the primary AI input changes the clinical question being answered. Noncontrast CT is available earlier and more broadly, but the large vessel occlusion sensitivity reported in the multicenter study leaves a meaningful false-negative rate [6]. The ACR-SIIM practice parameter directs practices to document routing rules, inclusion and exclusion criteria, and qualified end-user training logs when deploying imaging AI [2]. It also recommends that manufacturers provide summaries of training data, internal and external evaluation data, and performance in relevant subgroups [2]. These documentation requirements matter because the same AI module can perform differently across scanner protocols and patient populations.
What to Request from a Vendor Before Local Validation
Request the manufacturer's intended use documentation and release notes, including model versioning and any FDA-authorized predetermined change control plan [2]. Ask for summaries of training data, internal and external evaluation data, and performance in relevant subgroups such as anterior versus posterior circulation occlusions [2]. Confirm whether the tool's reported sensitivity and specificity were measured on noncontrast CT, CT angiography, or both, since the multicenter study reported different performance characteristics for hemorrhage and large vessel occlusion modules on noncontrast CT [6]. Finally, request the notification latency specification and the routing options for DICOM, Health Level Seven, or Fast Healthcare Interoperability Resources integration [2].
Evidence Limitations: Observational Designs and Vendor Concentration
The workflow interval reductions reported in the 2026 meta-analysis should be read with attention to study design. The review is classified as Level 2c, a systematic review of randomized clinical trials and observational studies, and its conclusion explicitly states that randomized controlled trials are still needed [1]. The keywords for the review name RAPID.AI and Viz.AI, and the cited companion meta-analysis focuses specifically on Viz.ai software for automated emergent large vessel occlusion detection [1]. This concentration means the pooled estimates may not generalize to other commercial or locally developed tools.
A broader survey of 84 peer-reviewed articles on AI in acute stroke imaging identifies additional translation barriers: lack of external validation, high annotation costs, demands of real-time processing, and poor prospective evidence [3]. The survey also notes that intracerebral hemorrhage and acute ischemic stroke follow different clinical decision pathways, which affects model design, data requirements, annotation strategies, and evaluation methods [3]. For a workflow evaluation, this means a tool validated primarily on ischemic stroke cases should not be assumed to perform equivalently on hemorrhage detection without separate evidence.
A Concrete Evaluation Example: Telestroke Triage with a Parallel Reader
Consider a suggested evaluation design for a regional hub-and-spoke telestroke network. The network would run an AI triage module on all noncontrast CT and CT angiography studies acquired at spoke sites for suspected acute stroke. The AI notification would route to the on-call telestroke physician in parallel with the existing image transmission, while the formal radiology interpretation continues on its normal timeline. The primary outcome would be time from imaging acquisition to a documented treatment decision for intravenous thrombolysis or endovascular therapy.
The evaluation would require three measurement layers. First, the network would record the AI notification timestamp and the clinician acknowledgment timestamp to isolate the software latency from human response time. Second, it would compare AI-detected large vessel occlusion cases against the final neuroradiologist ground truth to calculate local sensitivity and specificity, since the multicenter study reported 81.6% sensitivity for noncontrast CT large vessel occlusion detection [6]. Third, it would track false-positive notifications and their effect on clinician alert fatigue. This design is a suggestion, not a tested protocol, and it would require local institutional review board approval and data-use agreements consistent with the privacy restrictions described in the multicenter study [6].
Governance and Monitoring After Deployment
The ACR-SIIM practice parameter frames AI deployment as an ongoing governance activity rather than a one-time installation. It recommends that a governance group meet regularly and keep minutes that record decisions, risk acceptances, and defined rollback or sunset criteria [2]. Postdeployment monitoring data and drift checks should be documented, along with acceptance and rejection logging configuration [2]. For stroke imaging AI, drift monitoring is particularly relevant because scanner replacement, protocol changes, or shifts in the patient population can alter the distribution of inputs the model receives.
The AHA scientific statement adds a regulatory and equity dimension. It states that AI models should be evaluated for generalizability across diverse populations, and that ongoing bias surveillance throughout the AI life cycle is essential to promote equitable health care outcomes [7]. It also notes that transparent reporting of AI model performance in the real world is essential, and that data security concerns should be addressed in collaboration with information technology [7]. These are process requirements, not performance benchmarks, but they determine whether a workflow change is sustainable under institutional review and accreditation scrutiny.
Sources & references
- Impact of Artificial Intelligence-Based Triage on Stroke Workflow Metrics: A Systematic Review and Meta-Analysis | CardioVascular and Interventional Radiology | Springer Nature Link · doi.org
- acr–siim practice parameter for imaging artificial intelligence (ai) · gravitas.acr.org
- Artificial intelligence in acute stroke imaging: A comprehensive survey from imaging assessment to outcome prediction - ScienceDirect · www.sciencedirect.com
- Deep Learning Applications in Imaging of Acute Ischemic Stroke: A Systematic Review and Narrative Summary | Radiology · pubs.rsna.org
- Prospective Evaluation of Artificial Intelligence Imaging Support Software for Acute Ischemic Stroke in the Mayo Clinic Telestroke Network - PMC · pmc.ncbi.nlm.nih.gov
- Evaluation of a Deep Learning Tool for Detecting Large Vessel Occlusion and Intracranial Hemorrhage on Noncontrast Computed Tomography Scans | Stroke: Vascular and Interventional Neurology · www.ahajournals.org
- Creating Virtual Stroke Networks: Current and Future Role of Artificial Intelligence, Mobile Imaging Applications, and Telehealth in Triage and Treatment of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association | Stroke · www.ahajournals.org
- Creating Virtual Stroke Networks: Current and Future Role of Artificial Intelligence, Mobile Imaging Applications, and Telehealth in Triage and Treatment of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association | Stroke · www.ahajournals.org